4//SEC Filing
Hassard James 4
Accession 0001209191-23-015619
CIK 0001658247other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:47 PM ET
Size
7.3 KB
Accession
0001209191-23-015619
Insider Transaction Report
Form 4
Hassard James
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-03-01+14,000→ 14,000 total - Award
Stock Option (right to buy)
2023-03-01+65,250→ 65,250 totalExercise: $19.64Exp: 2033-02-28→ Common Stock (65,250 underlying)
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2024.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 1, 2023.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001799357
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:47 PM ET
- Size
- 7.3 KB